140 related articles for article (PubMed ID: 26283195)
1. Preparation and Evaluation of Diclofenac Sodium Tablet Coated with Polyelectrolyte Multilayer Film Using Hypromellose Acetate Succinate and Polymethacrylates for pH-Dependent, Modified Release Drug Delivery.
Jeganathan B; Prakya V; Deshmukh A
AAPS PharmSciTech; 2016 Jun; 17(3):578-87. PubMed ID: 26283195
[TBL] [Abstract][Full Text] [Related]
2. Interpolyelectrolyte complexes of Eudragit® EPO with hypromellose acetate succinate and Eudragit® EPO with hypromellose phthalate as potential carriers for oral controlled drug delivery.
Jeganathan B; Prakya V
AAPS PharmSciTech; 2015 Aug; 16(4):878-88. PubMed ID: 25591951
[TBL] [Abstract][Full Text] [Related]
3. Biopharmaceutical evaluation of diclofenac sodium controlled release tablets prepared from gum karaya--chitosan polyelectrolyte complexes.
Lankalapalli S; Kolapalli RM
Drug Dev Ind Pharm; 2012 Jul; 38(7):815-24. PubMed ID: 22087874
[TBL] [Abstract][Full Text] [Related]
4. STUDYING THE IMPACT OF FORMULATION AND PROCESSING PARAMETERS ON THE RELEASE CHARACTERISTICS FROM HYDROXYPROPYL METHYLCELLULOSE MATRIX TABLETS OF DICLOFENAC.
Elzayat EM; Abdel-Rahman AA; Ahmed SM; Alanazi FK; Habib WA; Sakr A
Acta Pol Pharm; 2016; 73(2):439-52. PubMed ID: 27180437
[TBL] [Abstract][Full Text] [Related]
5. Modulation of microenvironmental pH for dual release and reduced in vivo gastrointestinal bleeding of aceclofenac using hydroxypropyl methylcellulose-based bilayered matrix tablet.
Kang WH; Nguyen HV; Park C; Choi YW; Lee BJ
Eur J Pharm Sci; 2017 May; 102():85-93. PubMed ID: 28263912
[TBL] [Abstract][Full Text] [Related]
6. Insights into the mechanisms of chitosan-anionic polymers-based matrix tablets for extended drug release.
Li L; Wang L; Li J; Jiang S; Wang Y; Zhang X; Ding J; Yu T; Mao S
Int J Pharm; 2014 Dec; 476(1-2):253-65. PubMed ID: 25290814
[TBL] [Abstract][Full Text] [Related]
7. Design, development and in vitro-in vivo study of a colon-specific fast disintegrating tablet.
Kshirsagar SJ; Bhalekar MR; Umap RR
Pharm Dev Technol; 2011 Oct; 16(5):449-56. PubMed ID: 20486875
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of free mixed-film of pectin/chitosan/Eudragit RS intended for sigmoidal drug delivery.
Ghaffari A; Navaee K; Oskoui M; Bayati K; Rafiee-Tehrani M
Eur J Pharm Biopharm; 2007 Aug; 67(1):175-86. PubMed ID: 17346954
[TBL] [Abstract][Full Text] [Related]
9. Some variables affecting the characteristics of Eudragit E-sodium alginate polyelectrolyte complex as a tablet matrix for diltiazem hydrochloride.
Yusif RM; Abu Hashim II; El-Dahan MS
Acta Pharm; 2014 Mar; 64(1):89-104. PubMed ID: 24670354
[TBL] [Abstract][Full Text] [Related]
10. Design and evaluation of an extended-release matrix tablet formulation; the combination of hypromellose acetate succinate and hydroxypropylcellulose.
Fukui S; Yano H; Yada S; Mikkaichi T; Minami H
Asian J Pharm Sci; 2017 Mar; 12(2):149-156. PubMed ID: 32104324
[TBL] [Abstract][Full Text] [Related]
11. [Preparation of tablets containing enteric-coated diclofenac sodium pellets].
Qi XL; Zhu JB; Chen SJ
Yao Xue Xue Bao; 2008 Jan; 43(1):97-101. PubMed ID: 18357741
[TBL] [Abstract][Full Text] [Related]
12. Multi-kinetic release of benznidazole-loaded multiparticulate drug delivery systems based on polymethacrylate interpolyelectrolyte complexes.
García MC; Martinelli M; Ponce NE; Sanmarco LM; Aoki MP; Manzo RH; Jimenez-Kairuz AF
Eur J Pharm Sci; 2018 Jul; 120():107-122. PubMed ID: 29705213
[TBL] [Abstract][Full Text] [Related]
13. In vitro-in vivo evaluation of xanthan gum and eudragit inter polyelectrolyte complex based sustained release tablets.
Deb TK; Ramireddy B; Moin A; Shivakumar HG
Int J Pharm Investig; 2015; 5(1):65-72. PubMed ID: 25599035
[TBL] [Abstract][Full Text] [Related]
14. Film coated tablets (ColoPulse technology) for targeted delivery in the lower intestinal tract: influence of the core composition on release characteristics.
Schellekens RC; Baltink JH; Woesthuis EM; Stellaard F; Kosterink JG; Woerdenbag HJ; Frijlink HW
Pharm Dev Technol; 2012; 17(1):40-7. PubMed ID: 20923321
[TBL] [Abstract][Full Text] [Related]
15. Formulation and pharmacokinetics of colon-specific double-compression coated mini-tablets: Chronopharmaceutical delivery of ketorolac tromethamine.
Vemula SK
Int J Pharm; 2015 Aug; 491(1-2):35-41. PubMed ID: 26056929
[TBL] [Abstract][Full Text] [Related]
16. A novel coating concept for ileo-colonic drug targeting: proof of concept in humans using scintigraphy.
Varum FJ; Hatton GB; Freire AC; Basit AW
Eur J Pharm Biopharm; 2013 Aug; 84(3):573-7. PubMed ID: 23348235
[TBL] [Abstract][Full Text] [Related]
17. Release of poorly soluble drugs from HPMC tablets studied by FTIR imaging and flow-through dissolution tests.
van der Weerd J; Kazarian SG
J Pharm Sci; 2005 Sep; 94(9):2096-109. PubMed ID: 16052556
[TBL] [Abstract][Full Text] [Related]
18. Understanding the in vivo performance of enteric coated tablets using an in vitro-in silico-in vivo approach: case example diclofenac.
Kambayashi A; Blume H; Dressman J
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt B):1337-47. PubMed ID: 24056057
[TBL] [Abstract][Full Text] [Related]
19. Design and characterization of colon-specific drug delivery system containing paracetamol microsponges.
Jain V; Singh R
Arch Pharm Res; 2011 May; 34(5):733-40. PubMed ID: 21656358
[TBL] [Abstract][Full Text] [Related]
20. Evolution of a physiological pH 6.8 bicarbonate buffer system: application to the dissolution testing of enteric coated products.
Liu F; Merchant HA; Kulkarni RP; Alkademi M; Basit AW
Eur J Pharm Biopharm; 2011 May; 78(1):151-7. PubMed ID: 21255647
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
